Cyclosporine is an immunosuppressive agent used to treat organ rejection post-transplant. It also has use in certain other autoimmune diseases, treatment of organ rejection in kidney, liver, and heart allogeneic transplants, rheumatoid arthritis when the condition has not adequately responded to methotrexate. Also, it is a second-line agent for ALS and graft vs. host disease. It also has other FDA and non-FDA-approved indications. This activity reviews the mechanism of action, adverse event profile, toxicity, dosing, pharmacodynamics, and monitoring of cyclosporine, pertinent for interprofessional team members in treating conditions where cyclosporine is indicated.

**Objectives:**
- Identify the mechanism of action of cyclosporine.
- Review the FDA and non-FDA-approved indications for cyclosporine.
- Explain the importance of monitoring for toxicity with cyclosporine.
- Summarize the importance of interprofessional communication in improving care coordination among the interprofessional team when initiating cyclosporine therapy.